Intravenous immunoglobulin in pregnancy: A chance for patients with an autoimmune disease

Israel Medical Association Journal

Volumn 9, Issue 7, 2007, Pages 553-554

  Tincani, Angela ^a   Scarsi, Mirko ^a   Franceschini, Franco ^a   Cattaneo, Roberto ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Antiphospholipid syndrome; Congenital heart block; Intravenous immunoglobulin; Neonatal lupus; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; BETA2 GLYCOPROTEIN 1 ANTIBODY; BETAMETHASONE; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; DEXAMETHASONE; FC RECEPTOR; HEPARIN; IMMUNOGLOBULIN G; LA ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; RO ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; CLINICAL TRIAL; CONGENITAL HEART BLOCK; DRUG EFFICACY; DRUG PENETRATION; EDITORIAL; FETUS DISEASE; FETUS ECHOGRAPHY; HUMAN; LOW DRUG DOSE; NONHUMAN; PLACENTAL TRANSFER; PREGNANCY COMPLICATION; PREGNANT WOMAN; PROTEIN BINDING; PROTEIN INDUCTION; THROMBOCYTOPENIA;

ADRENAL CORTEX HORMONES; ANTIBODIES, ANTINUCLEAR; ANTIPHOSPHOLIPID SYNDROME; FEMALE; FIBRINOLYTIC AGENTS; HEART BLOCK; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 34547597719     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. Stojanovich L, Mikovic Z, Mandic V, Popovich-Kuzmanovich D. Treatment of antiphospholipid syndrome in pregnancy with low doses of intravenous immunoglobulin. IMAJ 2007;9:555-6.
2. Ostensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006;8:209
3. Radder CM, Roelen DL, van de Meer-Prins EM, Claas FH, Kahnai HH, Brand A. The immunologic profile of infants born after maternal immunoglobulin treatment and intrauterine platelet transfusions for fetal/neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 2004;191:815-20.
4. Sherer Y, Levy Y, Shoenfeld Y. Intravenous immunoglobulin therapy of antiphospholipid syndrome. Rheumatology (Oxford) 2000;39: 421-6.
5. Bakimer R, Guilburd B, Zurgil N, Shoenfeld Y. The effect of intravenous gamma-globulin on the induction of experimental antiphospholipid syndrome. Clin Immunol Immunopathol 1993;69:97-102.
6. Triolo G, Ferrante G, Ciccia F, et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 2003;48:728-31.
7. Branch DW, Peaceman AM, Druzin M, et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 2000;182:122-7.
8. Tincani A, Branch W, Levy RA, et al. Treatment of pregnant patients with antiphospholipid syndrome. Lupus 2003;12:524-9.
9. Brucato A, Frassi M, Franceschini F, et al. Risk of congenital heart block in newborns of other with anti-Ro/SSA antibodies detected by counter-immunoelectrophoresis. Arthritis Rheum 2001;44:1832-5.
10. Solomon DG, Rupel A, Buyon JP. Birth order and recurrence rate in autoantibody-associated congenital heart block: implication for pathogenesis and family counseling. Lupus 2003;12:646-7.
11. Tran HB, Macardle PJ, Hiscock J, et al. Anti-La/SSB antibodies transported across the placenta bind apoptotic cells in fetal organs targeted in neonatal lupus. Arthritis Rheum 2002;46:1572-9.
12. Hughes G. The eradication of congenital heart block. Lupus 2004;7:489.
13. Costedoat-Chalumeau N, Amoura Z, Le Thi Hong D, et al. Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis 2003;62:1010-12.
14. Dodic M, Samuel C, Moritz K, et al. Impaired cardiac functional reserve and left ventricular hypertrophy in adult sheep after prenatal dexamethasone exposure. Circ Res 2001;89:623-9.
15. Spinillo A, Viazzo F, Colleoni R, et al. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity. Am J Obstet Gynecol 2004;191:217-24.